Screening for F508del as a first step in the molecular diagnosis of cystic fibrosis

OBJECTIVE: To determine the relevance of screening for the F508del mutation of the cystic fibrosis transmembrane conductance regulator gene as a first step in the genetic diagnosis of cystic fibrosis (CF) by associating the genotype with various clinical variables. METHODS: We evaluated 180 CF...

Full description

Bibliographic Details
Main Authors: Fernando Augusto de Lima Marson, Carmen Silvia Bertuzzo, Maria Angela Goncalves de Oliveira Ribeiro, Antonio Fernando Ribeiro, Jose Dirceu Ribeiro
Format: Article
Language:English
Published: Sociedade Brasileira de Pneumologia e Tisiologia 2013-06-01
Series:Jornal Brasileiro de Pneumologia
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132013000300306&lng=en&tlng=en
_version_ 1819092485537792000
author Fernando Augusto de Lima Marson
Carmen Silvia Bertuzzo
Maria Angela Goncalves de Oliveira Ribeiro
Antonio Fernando Ribeiro
Jose Dirceu Ribeiro
author_facet Fernando Augusto de Lima Marson
Carmen Silvia Bertuzzo
Maria Angela Goncalves de Oliveira Ribeiro
Antonio Fernando Ribeiro
Jose Dirceu Ribeiro
author_sort Fernando Augusto de Lima Marson
collection DOAJ
description OBJECTIVE: To determine the relevance of screening for the F508del mutation of the cystic fibrosis transmembrane conductance regulator gene as a first step in the genetic diagnosis of cystic fibrosis (CF) by associating the genotype with various clinical variables. METHODS: We evaluated 180 CF patients regarding the F508del mutation. The clinical data were obtained from the medical records of the patients and from interviews with their parents or legal guardians. RESULTS: Of the 180 patients studied, 65 (36.1%) did not carry the F508del mutation (group 0 [G0]), 67 (37.2%) were F508del heterozygous (G1), and 48 (26.7%) were F508del homozygous (G2). All three groups showed associations with the clinical variables. Homozygosis was associated with younger patients, younger age at CF diagnosis, and younger age at the first isolation of Pseudomonas aeruginosa (PA), as well as with higher prevalence of pancreatic insufficiency (PI) and non-mucoid PA (NMPA) colonization. In comparison with G1+G2 patients, G0 patients were older; first experienced clinical symptoms, digestive disease, and pulmonary disease at an older age; were older at CF diagnosis and at first PA isolation; and had a lower prevalence of PI and meconium ileus, as well as of colonization by NMPA, mucoid PA, and Burkholderia cepacia. In G1 patients, values were intermediate for age at CF diagnosis; age at first PA isolation, first pulmonary symptoms, and first clinical manifestations; MPA colonization; and OR for PI. CONCLUSIONS: The identification of F508del in 63.9% of the patients studied showed that this can be a useful tool as a first step in the genetic diagnosis of CF. The F508del genotype was associated with clinical severity of the disease, especially with the variables related to CF onset.
first_indexed 2024-12-21T22:56:22Z
format Article
id doaj.art-f8f1edcd1e094d7a98b42d83fb192479
institution Directory Open Access Journal
issn 1806-3756
language English
last_indexed 2024-12-21T22:56:22Z
publishDate 2013-06-01
publisher Sociedade Brasileira de Pneumologia e Tisiologia
record_format Article
series Jornal Brasileiro de Pneumologia
spelling doaj.art-f8f1edcd1e094d7a98b42d83fb1924792022-12-21T18:47:26ZengSociedade Brasileira de Pneumologia e TisiologiaJornal Brasileiro de Pneumologia1806-37562013-06-0139330631610.1590/S1806-37132013000300007S1806-37132013000300306Screening for F508del as a first step in the molecular diagnosis of cystic fibrosisFernando Augusto de Lima MarsonCarmen Silvia BertuzzoMaria Angela Goncalves de Oliveira RibeiroAntonio Fernando RibeiroJose Dirceu RibeiroOBJECTIVE: To determine the relevance of screening for the F508del mutation of the cystic fibrosis transmembrane conductance regulator gene as a first step in the genetic diagnosis of cystic fibrosis (CF) by associating the genotype with various clinical variables. METHODS: We evaluated 180 CF patients regarding the F508del mutation. The clinical data were obtained from the medical records of the patients and from interviews with their parents or legal guardians. RESULTS: Of the 180 patients studied, 65 (36.1%) did not carry the F508del mutation (group 0 [G0]), 67 (37.2%) were F508del heterozygous (G1), and 48 (26.7%) were F508del homozygous (G2). All three groups showed associations with the clinical variables. Homozygosis was associated with younger patients, younger age at CF diagnosis, and younger age at the first isolation of Pseudomonas aeruginosa (PA), as well as with higher prevalence of pancreatic insufficiency (PI) and non-mucoid PA (NMPA) colonization. In comparison with G1+G2 patients, G0 patients were older; first experienced clinical symptoms, digestive disease, and pulmonary disease at an older age; were older at CF diagnosis and at first PA isolation; and had a lower prevalence of PI and meconium ileus, as well as of colonization by NMPA, mucoid PA, and Burkholderia cepacia. In G1 patients, values were intermediate for age at CF diagnosis; age at first PA isolation, first pulmonary symptoms, and first clinical manifestations; MPA colonization; and OR for PI. CONCLUSIONS: The identification of F508del in 63.9% of the patients studied showed that this can be a useful tool as a first step in the genetic diagnosis of CF. The F508del genotype was associated with clinical severity of the disease, especially with the variables related to CF onset.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132013000300306&lng=en&tlng=enFibrose cisticaRegulador de Condutancia Transmembrana em Fibrose CisticaGenotipoMutacao
spellingShingle Fernando Augusto de Lima Marson
Carmen Silvia Bertuzzo
Maria Angela Goncalves de Oliveira Ribeiro
Antonio Fernando Ribeiro
Jose Dirceu Ribeiro
Screening for F508del as a first step in the molecular diagnosis of cystic fibrosis
Jornal Brasileiro de Pneumologia
Fibrose cistica
Regulador de Condutancia Transmembrana em Fibrose Cistica
Genotipo
Mutacao
title Screening for F508del as a first step in the molecular diagnosis of cystic fibrosis
title_full Screening for F508del as a first step in the molecular diagnosis of cystic fibrosis
title_fullStr Screening for F508del as a first step in the molecular diagnosis of cystic fibrosis
title_full_unstemmed Screening for F508del as a first step in the molecular diagnosis of cystic fibrosis
title_short Screening for F508del as a first step in the molecular diagnosis of cystic fibrosis
title_sort screening for f508del as a first step in the molecular diagnosis of cystic fibrosis
topic Fibrose cistica
Regulador de Condutancia Transmembrana em Fibrose Cistica
Genotipo
Mutacao
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132013000300306&lng=en&tlng=en
work_keys_str_mv AT fernandoaugustodelimamarson screeningforf508delasafirststepinthemoleculardiagnosisofcysticfibrosis
AT carmensilviabertuzzo screeningforf508delasafirststepinthemoleculardiagnosisofcysticfibrosis
AT mariaangelagoncalvesdeoliveiraribeiro screeningforf508delasafirststepinthemoleculardiagnosisofcysticfibrosis
AT antoniofernandoribeiro screeningforf508delasafirststepinthemoleculardiagnosisofcysticfibrosis
AT josedirceuribeiro screeningforf508delasafirststepinthemoleculardiagnosisofcysticfibrosis